Today's Date: December 7, 2022
Sara Romine Joins Lockton as U.S. General Counsel   •   Impact Podcast with John Shegerian Features Hearst’s David Carey   •   Crowley and Wreaths Across America to Host Wreath Laying Ceremony to Honor Veteran Roberto Clemente 50 Years After His Passing   •   Agilent Again Named to Newsweek’s List of America’s Most Responsible Companies   •   2022 Export Practitioner Monthly Subscription: Detailed Look at US Export Licensing Requirements and Enforcement Policies - Rese   •   BWXT Starts Production of TRISO Fuel for First U.S. Generation IV Microreactor   •   SpineThera Announces Results for SX600 from its SALIENT Phase 2 Sciatica Pain Clinical Trial Supporting the Potential for Best-I   •   Protecting more nature in partnership with Indigenous Peoples   •   INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Welltower Inc. and Encourages Investors wi   •   INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Veru Inc. (VERU) on Behalf of Investors   •   KERV Interactive Elevates Jay Wolff to Chief Revenue Officer, Tapping Former TikTok Executive Creed Pettit as SVP, Revenue &   •   Three Hightower Advisors Win Honors from InvestmentNews' Women to Watch Awards   •   Meijer Brightens Holiday for In-Store and Pickup Customers with Nearly $400,000 in Surprise Holiday Shopping Sprees   •   Populus Financial Group Donates $15,000 to Junior Achievement; Volunteers Teach JA in a Day   •   Library and Archives Canada announces First Nations, Inuit and Métis Nation organizations receiving 2022-2023 funding fro   •   Library and Archives Canada launches new Listen, Hear Our Voices funding cycle for 2023-2024, in support of First Nations, Inuit   •   Old Glory Bank Announces Code of Vets as Charitable Round-Up Partner   •   PALMER'S RELEASES FIRST BRAND CAMPAIGN IN PARTNERSHIP WITH THE SASHA GROUP   •   Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behal   •   Government of Canada invests in MEDTEQ+ to fund groundbreaking technologies that will benefit Canada's seniors and their familie
Bookmark and Share

Ferrum Health to Offer iCAD's Breast AI Technologies within its Women's Health AI Hub

Ferrum Health to Offer iCAD's Breast AI Technologies within its Women's Health AI Hub

PR Newswire

Ferrum Health to offer iCAD's Profound AI® for Digital Breast Tomosynthesis and PowerLook® Density Assessment solutions on its platform, empowering radiologists in the early detection of breast cancer and expanding access to iCAD's technology to more women nationwide.

SUNNYVALE, Calif., Nov. 23, 2022 /PRNewswire/ -- Ferrum Health, a leader in healthcare enterprise AI solutions, announces an agreement with iCAD, Inc., a global medical technology leader providing innovative cancer detection and therapy solutions, to offer iCAD's breast AI solutions on Ferrum Health's platform. The onboarding of iCAD's Profound AI® for Digital Breast Tomosynthesis (DBT) and PowerLook® Density Assessment tools expands Ferrum's suite of AI algorithms within its Women's Health AI Hub.

We are pleased to partner with iCAD to improve clinical confidence and optimize outcomes for women with AI.

"iCAD's breast AI solutions are playing a significant role in the rapid evolution of breast cancer screening," stated Pelu Tran, CEO and Co-Founder of Ferrum Health. "iCAD's leading-edge technologies offer clinicians the latest tools in the fight against breast cancer, and we are pleased to partner with the company to provide greater access to these AI tools, which are improving clinical confidence, enhancing patient care and optimizing outcomes for women."

ProFound AI® is a high-performing, deep-learning workflow solution that rapidly analyzes 3D images to detect malignant soft tissue densities and calcifications. It was clinically proven in a large reader study to improve radiologist sensitivity by 8%, reduce the rate of false positives and unnecessary recalls by 7%, and slash reading time for radiologists by 52.7%.[1] Trained with one of the largest available 3D image datasets, ProFound AI provides radiologists with crucial information, such as lesion Certainty of Finding and Case Scores, which assists in prioritizing caseloads, clinical decision-making, and may help to reduce physician burnout.

PowerLook® Density Assessment utilizes mammography images to categorize a women's breast density automating the process of breast density reporting. This automated density software offers top-performing accuracy, as well as consistent, accurate, and reliable density categorization for standardized risk-based screening stratification and reporting.

"The battle against breast cancer has never been more complex, and it is critical for radiologists to be armed with the latest tools to help them manage variability, volume, and burnout," said Stacey Stevens, President, and CEO of iCAD, Inc. "Our technologies offer solutions to the challenges radiologists face today and are ultimately helping them to detect cancer at its earliest possible stage."

Ferrum Health simplifies the selection, validation, and deployment of healthcare AI with a secure and scalable enterprise AI platform. Offering therapeutic AI Hubs within the oncology, orthopedic, cardiovascular, neurology, and women's health clinical space, Ferrum eases the selection of AI applications to support patient care. Ferrum is the only AI platform hosted locally to protect patient data eliminating the transfer of protected health information. Ferrum's unique validation approach ensures the performance of each tool on the chosen patient population and imaging technology, assisting health systems in driving improved patient outcomes.

About Ferrum Health

Ferrum Health developed an enterprise AI deployment platform to improve patient outcomes by democratizing health systems' access to the most innovative and impactful clinical AI technologies worldwide. The solution provides end-to-end AI Hubs able to run countless applications across many service lines and seamlessly integrates clinical imaging and administrative data. As of 2022, more than 750,000 unique patient records have been analyzed via the Ferrum AI Hub platform. For more information, visit and follow Ferrum on LinkedIn and Twitter.

About iCAD, Inc.

Headquartered in Nashua, NH, iCAD® is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit

Media Contact

Amy Vetter

Ferrum Health


Jessica Burns

iCAD, Inc.


[1] Conant, E et al. (2019). Improving Accuracy and Efficiency with Concurrent Use of Artificial Intelligence for Digital Breast Tomosynthesis. Radiology: Artificial Intelligence. 1 (4). Accessed via

Cision View original content to download multimedia:

SOURCE Ferrum Health Inc.

Back to top
| Back to home page

White House Live Stream
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Sounds Make the News ®
Atlanta - WAOK-Urban
Berkley / San Francisco - KPFA-Progressive
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
Washington - WOL-Urban

Listen to United Natiosns News